Last Updated 3 October 2022.
This vaccine is approved.
Approved in 49 countries
5 trials in 1 country
Approval Source: apnews.com
Non Replicating Viral Vector
Approved in 93 countries
38 trials in 17 countries
Approval Source: newsghana.com.gh
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form